Diagnostic and prognostic value of presepsin in preterm deliveries
Aim: To evaluate the association between serum presepsin
(soluble CD14 antigen subtype, sCD14-ST) levels
early after the signs of preterm delivery appeared and
within 48 hof preterm delivery, before 34th and 37th gestational
weeks; the comparison of presepsin and established
markers of inflammation severity; and the possible additional
value of concurrently evaluated ultrasound vaginal
cervicometry with serum presepsin measurement.